期刊文献+

白介素-18与新生血管性眼病

Interleukin-18 and neovascular eye disease
原文传递
导出
摘要 新生血管形成引起的眼病是眼科常见病和疑难病,常导致视功能严重障碍,由于对其发病机制研究有限,长期以来临床处理非常棘手,预后颇差。随着基础医学科学的发展,对眼内新生血管的形成有了重大发现,特别对某些促新生血管因子的研究,随之对抑制新生血管形成的研究也有了一些发展。目前,认为抑制新生血管生长是治疗这类疾病的关键,并且已有多种疗法问世。研究发现,白介素-18对新生血管有较强的抑制作用。本文从白介素-18的结构、功能、抑制新生血管的机制及其与眼部新生血管性疾病的关系等方面做一综述。 Ocular neovascularization is an common and stubborn disease,it usually lead to visual function damaged.Because of its pathogenesy research limited,it was difficult to clinical procedures and prognosis not very well.With the development of preclinical medicine, hava an important discover of Ocular neovascularization, especially study of angiogenic stimulators cytokines and inhibition angiopoiesis. At present, inhibition angiopoiesis considered as an important way to cure this kind diseases. Invest discover, Interleukin-18 have powerful inhibition effects to Neovascularization. In this article, we illustrate the structu ral and physicochemical characteristics of interleukin-18, the effect of lnterleukin-18,its mechanisms to inhibit neovascularization and the reference with Neovaseularization oculopathy.
作者 闾雯娟 唐宁
出处 《现代生物医学进展》 CAS 2010年第12期2379-2380,2384,共3页 Progress in Modern Biomedicine
关键词 白介素-18 新生血管 Interleukin- 18 Neovascularization
  • 相关文献

参考文献5

二级参考文献49

  • 1王继红,任凤,吴毓,田晓光,吴妍宁,赵宝昌.白眉蝮蛇去整合素Adinbitor的基因克隆、表达及其部分生物学活性[J].中国生物化学与分子生物学报,2004,20(6):745-749. 被引量:19
  • 2李文玲,单保恩,闫蕴力,郑力芬,李巧霞,周娜静,赵文清.IL-24基因对大鼠胶质瘤细胞生长状况的影响[J].中华肿瘤杂志,2005,27(3):141-144. 被引量:11
  • 3蒋常文,闫蕴力,马卫东,郑力芬,翟丽东,李文玲,曹翠丽.IL-18基因转染对大鼠C6胶质瘤细胞生长特性的影响[J].细胞生物学杂志,2005,27(3):339-342. 被引量:6
  • 4徐小华,浦佩玉,刘春祥,于士柱.脑胶质瘤患者的全身和局部免疫功能观察[J].中国神经精神疾病杂志,1995,21(6):323-325. 被引量:5
  • 5Antonia MJ, Sui H, Vassiliki P, et al. In vivo retinal gene expression in early diabetes. IOVS, 2001, 42: 3047-3057.
  • 6周红鹰 梅妍 卢友光.RFDD—PCR建立人类疾病差异表达谱方法研究[J].中华医学遗传学杂志,2005,22:293-296.
  • 7McInnes IB, Gracie JA, Leung BP, et al. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today,2000, 21:312-315.
  • 8Tahara H, Oikawa Y, Shimada A, et al. Systemic Administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J Immunol, 2003, 171: 5865-5875.
  • 9Esposito K, Nappo F, Giugliano F,et al. Cytokine milieu tends toward inflammation in type 2 diabetes (Letter). Diabetes Care,2003, 26:1647.
  • 10Aso Y, Okumura KI, Takebayashi K, et al. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intima-media wall thickness in patients with type 2diabetes. Diabetes Care,2003, 26:2622-2627.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部